Evidence map›Paper›PMID 39744561›Full record

ArticleJournal of Cancer2025

MiR-675 Inhibits Primary Ovarian Tumor Growth and Metastasis by Suppressing EMT and TGFβ Signaling.

Xinxin Zhao, Ziping Liu, Yongshuai Li, Shiji Song, Baojin Wang, Lawrence M Pfeffer, Wenjing Zhang, Junming Yue

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Cells · 2026
    Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xinxin ZhaoDepartment of Gynecology and Obstetrics, the Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Ziping LiuDepartment of Gynecology and Obstetrics, the Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Yongshuai LiDepartment of Pathology and Laboratory Medicine, College of Medicine, the University of Tennessee Health Science Center, Memphis, TN, 38163, USA.
Shiji SongDepartment of Thyroid Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Baojin WangDepartment of Gynecology and Obstetrics, the Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Lawrence M PfefferDepartment of Pathology and Laboratory Medicine, College of Medicine, the University of Tennessee Health Science Center, Memphis, TN, 38163, USA.
Wenjing ZhangCenter for Cancer Research, College of Medicine, the University of Tennessee Health Science Center, Memphis, TN, 38163, USA.
Junming YueDepartment of Pathology and Laboratory Medicine, College of Medicine, the University of Tennessee Health Science Center, Memphis, TN, 38163, USA.

Funding

Therapeutic targeting of the SWI/SNF chromatin remodeler to regulate GBM chemosensitivityR01CA281977 · NCI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI DUANE D MILLER, LAWRENCE MARC PFEFFER · 2023 to 2026
$2.0M
NCI NIH HHS R01 CA281977
6 · The paper itself

Abstract

MicroRNAs (miRNAs) can function as either tumor suppressors or oncogenes. This study explores the role of miR-675 in ovarian cancer (OC) using

Indexed as

EMTmiR-675orthotopic mouse modelovarian cancerTGFβ

Identifiers

PMID39744561
PMCPMC11660139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.